Timothy Henrich

Early Antiviral Treatment to Prevent Viral Persistence and Inflammation as Drivers of Long COVID: A Proof-of-Concept Mechanistic Trial

National Institute of Allergy and Infectious Diseases · U01

PI · $1.7M · University of California, San Francisco

Mechanisms of HIV Persistence and Inflammation in the Central Nervous Systems of Victims of Sudden Death

National Institute of Mental Health · R01

Contact PI · $819.4K · University of California, San Francisco

In Vivo Imaging and Post-Mortem Study of Methamphetamine Use on Immune Dysfunction and HIV Reservoir Transcription Among People with HIV on ART

National Institute on Drug Abuse · RM1

Contact PI · $4.7M · University of California, San Francisco

Whole Body Deep Tissue Characterization of the Human Virome

National Center for Complementary and Integrative Health · U01

Contact PI · $5.6M · University of California, San Francisco

Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID

Principal investigator · Active not recruiting · Phase 2

Timothy Henrich

Imaging Immune Activation in COVID-19

Principal investigator · Recruiting · Phase 2

CellSight Technologies, Inc.

PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)

Principal investigator · Recruiting · Phase 1

University of California, San Francisco

Imaging Immune Activation in HIV by PET-MR

Principal investigator · Recruiting · Phase 2

CellSight Technologies, Inc.